Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
Clinical trial NCT00979602 · COMPLETED
Trial details
- NCT number
- NCT00979602
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-09
- Primary completion
- 2011-01-10
- Enrollment
- 4048
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.